The Expanded Use of HPV Testing in Gynecologic Practice per ASCCP-Guided Management Requires the Use of Well-Validated Assays-Reference-Cited by-同舟云学术

The Expanded Use of HPV Testing in Gynecologic Practice per ASCCP-Guided Management Requires the Use of Well-Validated Assays

Published:2007-03 Issue:3 Volume:127 Page:335-337
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Stoler Mark H.,Castle Philip E.,Solomon Diane,Schiffman Mark

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/127/3/335/4987967/ajcpath127-0335.pdf

Reference16 articles.

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189:12-19.

2. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993; 85:958-964.

3. Stoler MH. New Bethesda terminology and evidence-based management guidelines for cervical cytology findings [editorial]. JAMA. 2002; 287:2140-2141.

4. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006; 119:1095-1101.

5. Titus K. Making a valid point about HPV tests. CAP Today. September 2006:1.

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Significance of Cytology, Biopsy, and HPV Testing;Colposcopy;2023

2. HPV-Testverfahren;Kolposkopie in der Praxis;2023

3. Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment;Diagnostics;2022-07-19

4. False Negative Results in Cervical Cancer Screening—Risks, Reasons and Implications for Clinical Practice and Public Health;Diagnostics;2022-06-20

5. Genotyping of human papillomavirus DNA in Wielkopolska region;Ginekologia Polska;2021-09-14